中性粒细胞与淋巴细胞比值与乙肝及乙肝肝硬化关系研究

夏银银, 孙平. 中性粒细胞与淋巴细胞比值与乙肝及乙肝肝硬化关系研究[J]. 中国中西医结合消化杂志, 2017, 25(2): 101-104. doi: 10.3969/j.issn.1671-038X.2017.02.06
引用本文: 夏银银, 孙平. 中性粒细胞与淋巴细胞比值与乙肝及乙肝肝硬化关系研究[J]. 中国中西医结合消化杂志, 2017, 25(2): 101-104. doi: 10.3969/j.issn.1671-038X.2017.02.06
XIA Yin-yin, SUN Ping. Relationship between neutrophil to lymphocyte ratio level and hepatitis B virus infection/HBV induced liver cirrhosis[J]. Chin J Integr Tradit West Med Dig, 2017, 25(2): 101-104. doi: 10.3969/j.issn.1671-038X.2017.02.06
Citation: XIA Yin-yin, SUN Ping. Relationship between neutrophil to lymphocyte ratio level and hepatitis B virus infection/HBV induced liver cirrhosis[J]. Chin J Integr Tradit West Med Dig, 2017, 25(2): 101-104. doi: 10.3969/j.issn.1671-038X.2017.02.06

中性粒细胞与淋巴细胞比值与乙肝及乙肝肝硬化关系研究

详细信息
    作者简介:

    夏银银,女,学士,主治医师,从事感染性疾病及肝病的研究

    通讯作者: 夏银银,E-mail:xyy_ah@163.com
  • 中图分类号: R575.2

Relationship between neutrophil to lymphocyte ratio level and hepatitis B virus infection/HBV induced liver cirrhosis

More Information
  • [目的]研究乙型肝炎患者外周血中性粒细胞和淋巴细胞计数随乙型肝炎病情进展变化情况,并探讨中性粒细胞与淋巴细胞比值(NLR)与乙型肝炎及乙肝肝硬化间的关系。[方法]将健康对照组20例,乙型肝炎组25例,乙肝肝硬化组90例患者应用血液全自动分析仪进行外周血白细胞计数并计算NLR,对比分析3组间NLR水平差异。采用Child-Pugh评分系统对乙肝肝硬化组90例患者进行分级,且分析NLR水平同Child-Pugh评分相关性。[结果]①与健康对照组比较,乙型肝炎组和乙肝肝硬化组患者具有更低水平的NLR (P<0.05);②在乙肝肝硬化患者中,随着肝脏纤维化及损伤程度加重,NLR水平呈显著下降趋势;③线性分析显示,Child-Pugh评分会随NLR的升高而降低,NLR水平同乙肝肝硬化患者Child-Pugh评分呈负相关(P<0.05)。[结论]NLR水平同乙型肝炎和乙肝肝硬化病理进程密切相关,伴随乙型肝炎的进展,NLR水平显著降低;NLR是Child-Pugh评分的预测因子,其水平与乙肝肝硬化和肝功能损伤程度负相关,可辅助预测乙型肝炎患者肝功能情况,评估肝脏纤维化程度。
  • 加载中
  • [1]

    李杰, 庄辉.病毒性肝炎流行病学进展[J].肝脏, 2012, 17(1):2-5.

    [2]

    王贵强, 王福生, 成军, 等.慢性乙型肝炎防治指南(2015年版)[J].中国肝脏病杂志:电子版, 2015, 9(3):1-18.

    [3]

    Guidotti L G, Chisari F V.Immunobiology and pathogenesis of viral hepatitis[J].Annu Rev Pathol, 2006, 1:23-61.

    [4]

    Sun W B.How is radiofrequency ablation going in treating hepatocellular carcinoma in China?[J].Austral Asian J Cancer, 2008, 7(4):221-224.

    [5]

    Gremion C, Cerny A.Hepatitis C virus and the immune system:a concise review[J].Rev Med Virol, 2005, 15(4):235-268.

    [6]

    Lavanchy D D.Lavanchy D.Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures[J].J Viral Hepat, 2004, 11(2):97-107.

    [7]

    Czaja A J.Hepatic inflammation and progressive liver fibrosis in chronic liver disease[J].World J Gastroenterol, 2014, 20(10):2515-2532.

    [8]

    Saile B, Ramadori G.Inflammation, damage repair and liver fibrosis——role of cytokines and different cell types[J].Z Gastroenterol, 2007, 45(1):77-86.

    [9]

    Kershenobich S D, Weissbrod A B.Liver fibrosis and inflammation.A review[J].Ann Hepatol, 2003, 2(4):159-163.

    [10]

    Kekilli M, Tanoglu A, Sakin Y S, et al.Is the neutrophil to lymphocyte ratio associated with liverfibrosis in patients with chronic hepatitis B?[J].World J Gastroenterol, 2015, 21(18):5575-5581.

    [11]

    Durand F, Valla D.Assessment of prognosis of cirrhosis[J].Seminars Liver Dis, 2008, 28(1):110-122.

    [12]

    胡晓丽, 赵宏伟, 吴晓岩等.乙型肝炎病毒感染的流行现状[J].临床肝胆病杂志, 2012, 28(6):413-416.

    [13]

    王岩, 贾继东.中国大陆抗击乙型肝炎病毒感染的进展和挑战[J].临床肝胆病杂志, 2010, 26(4):341-343.

    [14]

    Abdelrazik A, Mousa N, Besheer T A, et al.Neutrophil to lymphocyte ratio as a reliable marker to predict insulin resistance and fibrosis stage in chronic hepatitis C virus infection[J].Acta Gastroenterol Belgica, 2015, 78(4):2169-2172.

    [15]

    Mera K, Uto H, Mawatari S, et al.Serum levels of apoptosis inhibitor of macrophage are associated with hepatic fibrosis in patients with chronic hepatitis C[J].Bmc Gastroenterol, 2014, 14(1):1-10.

    [16]

    Buttarello M, Plebani M.Automated blood cell counts:state of the art[J].Am J Clin Pathol, 2008, 130(1):104-116.

    [17]

    李冶刚, 张超飞, 郭希邦, 等.慢性乙型肝炎病毒感染者外周血淋巴细胞亚群的变化及检测意义[J].中国慢性病预防与控制, 2015, 23(10):775-776.

    [18]

    Lorenzini S, Andreone P.Stem Cell Therapy for Human Liver Cirrhosis:A Cautious Analysis of the Results[J].Stem Cells, 2007, 25(9):2383-2384.

    [19]

    Kishimoto Y, Shiota G, Wada K, et al.Frequent loss in chromosome 8 ploci in liver cirrhosis accompanying hepatocellular carcinoma[J].J Cancer Res Clin Oncol, 1996, 122(10):585-589.

    [20]

    Hashimoto N, Shimoda S, Kawanaka H, et al.Modulation of CD4+, T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis[J].Clin Exp Immunol, 2011, 165(2):243-250.

    [21]

    Denzer U, Arnoldy A, Kanzler S, et al.Prospective randomized comparison of minilaparoscopy and percutaneous liver biopsy:diagnosis of cirrhosis and complications[J].J Clin Gastroenterol, 2007, 41(1):103-110.

    [22]

    Terjung B, Lemnitzer I, Dumoulin F L, et al.Bleeding complications after percutaneous liver biopsy.An analysis of risk factors[J].Digestion, 2003, 67(3):138-145.

    [23]

    Cholongitas E, Senzolo M, Standish R, et al.A systematic review of the quality of liver biopsy specimens[J].Am J Clin Pathol, 2006, 125(5):710-721.

  • 加载中
计量
  • 文章访问数:  448
  • PDF下载数:  455
  • 施引文献:  0
出版历程
收稿日期:  2016-09-07

目录